# Clinical Validation of Breath Analyser Tests for Diagnosis of COVID-19.

> **NCT05094674** · NA · UNKNOWN · sponsor: **Tera Group** · enrollment: 500 (estimated)

## Conditions studied

- COVID-19

## Interventions

- **DIAGNOSTIC_TEST:** Breath Sample analysis

## Key facts

- **NCT ID:** NCT05094674
- **Lead sponsor:** Tera Group
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-10-22
- **Primary completion:** 2022-06-22
- **Final completion:** 2022-07-30
- **Target enrollment:** 500 (ESTIMATED)
- **Last updated:** 2021-10-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05094674

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05094674, "Clinical Validation of Breath Analyser Tests for Diagnosis of COVID-19.". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05094674. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*